Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ENANTIOS
Zurich, Zurich canton, Switzerlandenantios.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Commercial
01
Overview
Enantios has developed a proprietary ROA-based instrument for rapid, non-destructive structural analysis of chiral molecules and biologics. The technology enables faster drug development by providing detailed insights into molecular chirality, folding integrity, and batch-to-batch consistency. The first commercial instrument was delivered in April 2025 to an academic customer. Revenue generation began in early/mid–2024 with several paying customers across Switzerland and the EU. No clinical results are reported since the company does not develop therapeutics.
- Therapeutic areas
- Other
- Modalities
- Chiral small moleculesBiologics (including peptides and antibody-drug conjugates)
- Industry
- Drug Discovery Services
02
Partnerships
Two top ten pharmaceutical companies are customers of their Gen 1 instrumentSeveral paying customers in Switzerland/EU including academic labs
Beyond the preview
Go deeper on ENANTIOS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ENANTIOS.